Brief: Synact Pharma To Carry Out Directed Issues, Fully Guaranteed Rights Issue
Nov 20 (Reuters) - SynAct Pharma AB SYNACT.ST :
* INTENDS TO CARRY OUT DIRECTED ISSUES TOTALLING
APPROXIMATELY 45
MSEK AND A FULLY GUARANTEED RIGHTS ISSUE TOTALLING APPROXIMATELY
20 MSEK
* SUBSCRIPTION PRICE OF 8.65 SEK PER SHARE
Source text: ID:nMFN5smnfp
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026